- Hydroxycut adds new products to weight-loss line
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Report: Dietary supplements utilized as preventive health care can save health system tens of billions of dollars
- Most people managing diabetes interested in weight-loss programs
- Pharmagen launches Warfarin-friendly multivitamin
LEBANON, Pa. — Alli, pictured here at a CVS, is back on shelf. Supply issues earlier this year took many facings of GlaxoSmithKline's Alli nonprescription weight loss solution out of play, but no longer, as of earlier this summer. With Alli's absence, the hefty weight-loss solution fell behind Hydroxycut Advanced in number of units sold but still led all diet aids in sales with an 18.2% dollar share (to Hydroxycut Advanced's 9.6%). Sales of diet aid tablets dropped 5.5%, to $218.9 million for the 52 weeks ending April 15 across food, drug and mass outlets (excluding Walmart), so you can expect those comp numbers to show a marked improvement in January with the 2013 spate of New Year's Resolutions.